Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of the High Frequency Digit Triplet Test as a Screening Tool for Early Detection of Hearing Loss in Individuals With Cystic Fibrosis

NCT02252601 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.

NCT NCT02252601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02252601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of the High Frequency Digit Triplet Test as a Screening Tool for Early Detection of Hearing Loss in Individuals With Cystic Fibrosis
Lead sponsor
University of Nottingham
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2015
Completion date
Not reported
Enrollment
388 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis, sensorineural hearing loss